Clinical relevance of partial HPV genotyping in cervical cancer screening

Nature·Feb 4

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Researchers are studying the clinical relevance of partial HPV genotyping in cervical cancer screening, exploring its potential benefits and limitations. Some studies suggest that extended HPV genotyping may help individualize cervical cancer screening and improve triage of screen-positive cases, while others investigate its comparative effectiveness with other screening strategies. The utility of partial HPV genotyping in cervical cancer screening is being examined in various settings, including resource-limited areas and routine screening programs.

Full coverage

Minimal benefit of co-testing over HPV primary screening with cytology triage from resource-limited settings in China

Nature·Feb 26

An HPV Test With Extended Genotyping to Individualize Cervical Cancer Screening

Contemporary OB/GYN·Nov 13

Extended HPV genotyping and dual stain for the triage of primary HPV screen-positive cases: Practical guidance for the cytopathology laboratory

Wiley & Sons·Mar 8

Extended HPV genotyping by the BD Onclarity assay: concordance with screening HPV-DNA assays, triage biomarkers, and histopathology in women from the NTCC2 study

ASM Journals·Feb 12

Molecular triaging options for women testing HPV positive with self-collected samples

Frontiers·Sep 3

Comparative pilot study about HPV test with partial genotyping in primary screening versus other strategies for cervical cancer population screening, CRYGEN 16/18 study

Elsevier·May 4

Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening

Nature·Apr 3

Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer

Nature·Mar 21

View original report at Nature ↗

Fetching the latest headlines…